Specimen Collection Cards Market Size, Share, Report 2023-2032
The global specimen collection cards market size was estimated at around USD 0.47 billion in 2022 and it is projected to hit around USD 0.76 billion by 2032, growing at a CAGR of 4.94% from 2023 to 2032. The specimen collection cards market in the United States was accounted for USD 27.3 million in 2022.
Key Pointers
Report Scope of the Specimen Collection Cards Market
| Report Coverage | Details |
| Revenue Share of North America in 2022 | 42% |
| Revenue Forecast by 2032 | USD 0.76 billion |
| Growth Rate from 2023 to 2032 | CAGR of 4.94% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | QIAGEN; PerkinElmer Inc.; DBS System SA; Danaher Corporation; Eastern Business Forms, Inc.; Ahlstrom; ARCHIMED Life Science GmbH; GenTegra LLC; FortiusBio; CENTOGENE N.V. |
The growth of the market is attributed to favorable government regulations, efficient ergonomics, and increasing emphasis on non-invasive procedures. Moreover, an increasing number of product launches coupled with growing research and development activities are also expected to have a positive impact on market growth. During the initial phases of the pandemic, the demand for specimen collection cards was substantial due to the massive burden of testing and research activities associated with vaccine development.
However, as the vaccine and virus research proceeded further, the demand for substitute products increased due to comparatively higher applicability and availability. Further, the imposition of lockdowns and restrictions on the supply chain negatively impacted the specimen collection card industry.
The expansion of forensic toxicology applications had a significant impact on the market for specimen-collecting cards, pushing broad acceptance of these cards for efficient and dependable sample collection. Specimen collection cards have grown in popularity in forensic toxicology due to their ease, dependability, and capacity to store samples for extended periods. They have various benefits, such as noninvasiveness, reduced sample volume needs, and increased sample stability during transportation & storage, all of which lead to improved accuracy & efficiency in forensic toxicological testing.
Furthermore, the growth of the market is attributed to the increasing focus on personalized medicine, genetic testing, health monitoring, and well-being initiatives. Personalized medicine aims to customize medical treatments based on individual genetic profiles, lifestyle factors, and other relevant information. Genetic testing plays a vital role in this approach by providing insights into an individual's genetic makeup, enabling personalized diagnostics, treatment selection, and disease prevention strategies. Specimen collection cards have become essential tools in genetic testing processes, offering a convenient and reliable method of collecting various biological samples, such as saliva, blood, & tissue.
However, the market is majorly constrained by the challenges associated with sample integrity and storage. It is crucial to maintain the quality and stability of collected samples for accurate testing results. Sample contamination from various sources, including environmental pollutants, microorganisms, and chemicals, can lead to inaccurate test outcomes such as false positives or negatives.
Type Of Specimen Insights
The blood sample segment dominated the overall market with the largest revenue share of 90% in 2022. The dominance of the segment can be attributed to several benefits and product availability of dried blood spot collection cards worldwide. Furthermore, regulations related to newborn screening in several countries are expected to have a positive impact on segment growth. For instance, in February 2023, the North Carolina Department of Health and Human Services announced an update regarding the screening of newborns for two new additional diseases. As per the new mandate of the health department, the newborns will now also be screened for Mucopolysaccharidosis Type I (MPS I) and Pompe Disease.
The saliva segment is estimated to register a considerable CAGR during the forecast period. Ongoing research and development facilities are expected to offer a favorable environment for segment growth. For instance, in June 2022, OrisDX received the price for its innovation in saliva-based diagnostics for oral cancers. The company received funding of USD 1.76 million as an investment for progressing its research.
Material Insights
The cotton & cellulose-based material segment held a market share of 57% in 2022. Cotton and cellulose-based specimen collection cards offer distinct advantages in specimen collection and preservation. These advantages aid in increasing its adoption among various industries, thereby driving market growth. Cotton and cellulose-based specimen collection cards are more extensively used than fiber-based cards. Cellulose-based cards, such as the Whatman 903 cards, have been widely adopted and established as the standard in several laboratories and healthcare settings.
The fiber-based material segment is expected to register a substantial CAGR during the forecast period. The adoption of fiber-based specimen collection cards is increasing in various industries at a rapid pace. These cards are made from different materials, such as synthetic fibers, and offer unique advantages to cater to specific requirements. Moreover, the fiber-based specimen collection cards demand is driven by their specialized properties and suitability for specific applications.
Product Insights
The Whatman 903 product segment held a market share of 42% in 2022. The segment is anticipated to witness lucrative growth in the near future owing to an increase in adoption by various government-sponsored programs and research studies. For instance, in June 2022, Scientific Reports published a research paper on the assessment of VIDAS HIV Duo Quick and Anti-HCV assays for dried blood specimen (DBS)-based serosurveillance. The study stated that it used the 903 Protein Saver Card by Cytiva Whatman to collect blood samples for HCV and HIV detection.
The FTA segment is expected to register a substantial CAGR during the forecast period. The FTA card segment is expected to witness lucrative growth in the near future owing to its growing adoption across various clinical applications. For instance, in July 2022, research was conducted on the screening of genetic diseases in newborns through DBS. FTA is one of the filter papers widely used in newborn screening. The study used around 29 DBS sets of FTA by Thermo Fisher Scientific. This method is usually preferred for various applications, including organizations working with bacterial genetics research.
Distribution Channel Insights
The offline distribution channel segment held a market share of 71% in 2022. Offline channels, such as pharmacies, healthcare clinics, and diagnostic laboratories, offer convenient access to specimen collection cards for customers who prefer in-person shopping experiences. Healthcare clinics and hospitals with onsite pharmacies or diagnostic centers are additional offline channels where individuals can find specimen collection cards.
The online distribution channel segment is expected to register a significant CAGR during the forecast period. Online platforms offer a wide range of specimen collection cards for various sample types, including blood, saliva, urine, and stool. These cards are often sold individually or as part of home testing kits that include instructions and necessary components for sample collection.A few examples of online platforms providing specimen collection cards are Everlywell, HealthLabs, MyLab Box, and Personalabs.
End-use Insights
The hospitals & clinics end-use segment held a market share of 75% in 2022. Hospitals and clinics were key end-users of specimen collection cards in 2022, owing to mandatory newborn screening in various regions. In the U.S., approximately 98% of women give birth in hospitals. An increase in the capacity of hospitals and clinics is anticipated to boost the demand for specimen collection cards. For instance, the government of Australia announced a USD 70.12 billion (AUD 104.1 billion) budget for 2022-2023 on healthcare, which is 5.7% more than that of the last year.
The diagnostic center end-use segment is projected to register a considerable CAGR during the forecast period. Diagnostics centers are important users of specimen collection cards in the market. Hence, an increase in the number of diagnostics laboratories, coupled with a rise in diagnostic testing of HIV and HCV, is expected to boost DBS collection card market growth. As of August 2022, there were 24,802 diagnostic and medical labs in the U.S., with average 0.8% growth in the business of diagnostics & medical labs.
Application Insights
The newborn screening segment led the market with a revenue share of 26% in 2022. The segment growth is majorly attributed to the advancements in newborn screening, favorable government regulations, and excelling research & development for disease diagnosis. In addition, an increasing number of product launches and introductions are also expected to accelerate segment growth during the forecast period. For instance, In November 2022, PerkinElmer announced it received FDA marketing approval for its EONIS SCID-SMA assay kit to detect spinal muscular atrophy in newborns. The platform utilizes PCR to screen SCID and spinal muscular atrophy through a single DBS sample.
The research application segment is projected to grow at the fastest rate over the forecast period. Increasing investments in research & development activities coupled with a rising emphasis on the development of personalized medicines is estimated to accelerate the segment growth during the forecast period. In addition, various organizations are offering services for the bioanalysis of blood spot specimens and providing unique beneficial solutions that only DBS services can offer. For instance, Bioanalytical Systems, Inc. (BASi) can evaluate the bioanalysis of DBS and has established DBS analysis expertise at its bioanalytical facilities. Such solution-oriented initiatives by service companies are likely to boost segment growth.
Regional Insights
The North America region accounted for the largest market share of 42% in 2022. This can be attributed to the growing need to perform drug profiling for various medications, such as antiepileptics, immunosuppressants, and antibiotics. It is one of the key factors supporting the market growth. Furthermore, the presence of well-established healthcare infrastructure and the availability of government funding for research are among other factors anticipated to augment market growth in this region.
For instance, in January 2022, the National Institute of Justice allocated USD 4.5 million in funding for the Forensic Technology Center of Excellence. This funding aims to facilitate the dissemination of evidence-based knowledge and technological tools to aid criminal investigations and associated agencies.
Asia Pacific is estimated to register a considerable CAGR during the forecast period. Certain factors such as rising investments in research & development, increasing rate of product penetration, and advancements in diagnostics are projected to accelerate the Asia Pacific specimen collection cards industry by 2030.
Specimen Collection Cards Market Segmentations:
By Type Of Specimen
By Material
By Product
By Application
By Distribution Channel
By End-use Channel
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. End-use Channel Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Specimen Collection Cards Market
5.1. COVID-19 Landscape: Specimen Collection Cards Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Specimen Collection Cards Market, By Type Of Specimen
8.1. Specimen Collection Cards Market, by Type Of Specimen, 2023-2032
8.1.1. Blood
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Saliva
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Urine
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Buccal Cells
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Specimen Collection Cards Market, By Material
9.1. Specimen Collection Cards Market, by Material, 2023-2032
9.1.1. Cotton & Cellulose-based
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Fiber-based
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Specimen Collection Cards Market, By Product
10.1. Specimen Collection Cards Market, by Product, 2023-2032
10.1.1. Whatman 903
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Ahlstrom 226
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. FTA
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Specimen Collection Cards Market, By Application
11.1. Specimen Collection Cards Market, by Application, 2023-2032
11.1.1. New Born Screening (NBS)
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Infectious Diseases Testing
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Therapeutic Drug Monitoring
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Forensics
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Research
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. Wellbeing/Health Monitoring
11.1.6.1. Market Revenue and Forecast (2020-2032)
11.1.7. Other Applications
11.1.7.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Specimen Collection Cards Market, By Distribution Channel
12.1. Specimen Collection Cards Market, by Distribution Channel, 2023-2032
12.1.1. Online
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Offline
12.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Specimen Collection Cards Market, By End-use Channel
13.1. Specimen Collection Cards Market, by End-use Channel, 2023-2032
13.1.1. Hospitals & Clinics
13.1.1.1. Market Revenue and Forecast (2020-2032)
13.1.2. Diagnostics Centers
13.1.2.1. Market Revenue and Forecast (2020-2032)
13.1.3. Others
13.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 14. Global Specimen Collection Cards Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.1.2. Market Revenue and Forecast, by Material (2020-2032)
14.1.3. Market Revenue and Forecast, by Product (2020-2032)
14.1.4. Market Revenue and Forecast, by Application (2020-2032)
14.1.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.1.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.1.7.2. Market Revenue and Forecast, by Material (2020-2032)
14.1.7.3. Market Revenue and Forecast, by Product (2020-2032)
14.1.7.4. Market Revenue and Forecast, by Application (2020-2032)
14.1.8. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.1.8.1. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.1.9.2. Market Revenue and Forecast, by Material (2020-2032)
14.1.9.3. Market Revenue and Forecast, by Product (2020-2032)
14.1.9.4. Market Revenue and Forecast, by Application (2020-2032)
14.1.10. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.1.11. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.2.2. Market Revenue and Forecast, by Material (2020-2032)
14.2.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.4. Market Revenue and Forecast, by Application (2020-2032)
14.2.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.2.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.2.8.2. Market Revenue and Forecast, by Material (2020-2032)
14.2.8.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.9. Market Revenue and Forecast, by Application (2020-2032)
14.2.10. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.2.10.1. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.2.11.2. Market Revenue and Forecast, by Material (2020-2032)
14.2.11.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.12. Market Revenue and Forecast, by Application (2020-2032)
14.2.13. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.2.14. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.2.15.2. Market Revenue and Forecast, by Material (2020-2032)
14.2.15.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.15.4. Market Revenue and Forecast, by Application (2020-2032)
14.2.16. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.2.16.1. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.2.17.2. Market Revenue and Forecast, by Material (2020-2032)
14.2.17.3. Market Revenue and Forecast, by Product (2020-2032)
14.2.17.4. Market Revenue and Forecast, by Application (2020-2032)
14.2.18. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.2.18.1. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.3.2. Market Revenue and Forecast, by Material (2020-2032)
14.3.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.4. Market Revenue and Forecast, by Application (2020-2032)
14.3.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.3.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.3.7.2. Market Revenue and Forecast, by Material (2020-2032)
14.3.7.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.7.4. Market Revenue and Forecast, by Application (2020-2032)
14.3.8. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.3.9. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.3.10.2. Market Revenue and Forecast, by Material (2020-2032)
14.3.10.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.10.4. Market Revenue and Forecast, by Application (2020-2032)
14.3.11. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.3.11.1. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.3.12.2. Market Revenue and Forecast, by Material (2020-2032)
14.3.12.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.12.4. Market Revenue and Forecast, by Application (2020-2032)
14.3.12.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.3.12.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.3.13.2. Market Revenue and Forecast, by Material (2020-2032)
14.3.13.3. Market Revenue and Forecast, by Product (2020-2032)
14.3.13.4. Market Revenue and Forecast, by Application (2020-2032)
14.3.13.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.3.13.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.4.2. Market Revenue and Forecast, by Material (2020-2032)
14.4.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.4. Market Revenue and Forecast, by Application (2020-2032)
14.4.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.4.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.4.7.2. Market Revenue and Forecast, by Material (2020-2032)
14.4.7.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.7.4. Market Revenue and Forecast, by Application (2020-2032)
14.4.8. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.4.9. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.4.10.2. Market Revenue and Forecast, by Material (2020-2032)
14.4.10.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.10.4. Market Revenue and Forecast, by Application (2020-2032)
14.4.11. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.4.12. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.4.13.2. Market Revenue and Forecast, by Material (2020-2032)
14.4.13.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.13.4. Market Revenue and Forecast, by Application (2020-2032)
14.4.13.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.4.13.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.4.14.2. Market Revenue and Forecast, by Material (2020-2032)
14.4.14.3. Market Revenue and Forecast, by Product (2020-2032)
14.4.14.4. Market Revenue and Forecast, by Application (2020-2032)
14.4.14.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.4.14.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.5.2. Market Revenue and Forecast, by Material (2020-2032)
14.5.3. Market Revenue and Forecast, by Product (2020-2032)
14.5.4. Market Revenue and Forecast, by Application (2020-2032)
14.5.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.5.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.5.7.2. Market Revenue and Forecast, by Material (2020-2032)
14.5.7.3. Market Revenue and Forecast, by Product (2020-2032)
14.5.7.4. Market Revenue and Forecast, by Application (2020-2032)
14.5.8. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.5.8.1. Market Revenue and Forecast, by End-use Channel (2020-2032)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type Of Specimen (2020-2032)
14.5.9.2. Market Revenue and Forecast, by Material (2020-2032)
14.5.9.3. Market Revenue and Forecast, by Product (2020-2032)
14.5.9.4. Market Revenue and Forecast, by Application (2020-2032)
14.5.9.5. Market Revenue and Forecast, by Distribution Channel (2020-2032)
14.5.9.6. Market Revenue and Forecast, by End-use Channel (2020-2032)
Chapter 15. Company Profiles
15.1. QIAGEN
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. PerkinElmer Inc.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. DBS System SA
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Danaher Corporation
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Eastern Business Forms, Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Ahlstrom
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. ARCHIMED Life Science GmbH
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. GenTegra LLC
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. FortiusBio
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. CENTOGENE N.V.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers